Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| SB Syntax BioCompany profile Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine | $14.4M | Series A+Series A | Biotech | United States | Investors |
Ranked by rounds participated in · All time
AusperBio, Abcuro, Infinimmune
Epicrispr Biotechnologies, Draig Therapeutics, Triveni Bio
LifeMine Therapeutics, Ollin Biosciences, SonoThera
Leal Therapeutics, Khartis Therapeutics, Vedana Therapeutics
Leal Therapeutics, Amplifica Holdings Group, InduPro
Explore published rounds while the next edition is being prepared.
| PB Portal BiotechnologiesCompany profile Builds universal infrastructure for cell engineering across drug discovery and cell therapy Builds universal infrastructure for cell engineering across drug discovery and cell therapy | $9M | Undisclosed | Biotech | United States | Investors |
| G GeroCompany profile Uses physics-based AI and longitudinal human data to discover drugs targeting aging and age-related diseases Uses physics-based AI and longitudinal human data to discover drugs targeting aging and age-related diseases | $17M | Undisclosed | Biotech | Singapore | Investors |
| TB Triveni BioCompany profile Develops novel antibody treatments for immunological and inflammatory disorders Develops novel antibody treatments for immunological and inflammatory disorders | $65M | Series CSeries C+ | Biotech | United States | Investors |
| PL Pramaana LabsCompany profile Builds formal verification tools ensuring AI reliability in law, drug discovery, and tax prep Builds formal verification tools ensuring AI reliability in law, drug discovery, and tax prep | $27M | Seed | Biotech, Enterprise software | United States | Investors |
| VT Develops next-generation therapies for migraine prevention | $46M | Series A | Biotech | United States | Investors |
| SB Spot BiosystemsCompany profile Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines | $40M | Series B | Biotech | United States | Investors |
| E EmmecellCompany profile Develops magnetic cell delivery technologies for treating corneal and other ophthalmic diseases Develops magnetic cell delivery technologies for treating corneal and other ophthalmic diseases | Undisclosed | StrategicUndisclosed | Biotech | United States | Investors |
| D DioseveCompany profile Develops iPS cell-derived co-culture technology to improve oocyte maturation and reduce IVF treatment burden Develops iPS cell-derived co-culture technology to improve oocyte maturation and reduce IVF treatment burden | $7M | Series A+Series A | Biotech | Japan | Investors |
| RC Rainbow CropsCompany profile Combines AI, multiplex genome editing, and precision breeding to develop resilient crop varieties Combines AI, multiplex genome editing, and precision breeding to develop resilient crop varieties | €9.7M | Seed+Seed | Biotech, Agritech | Belgium | Investors |